The AI Doctor Will See You Now: Chatbot Risks and Regulatory Oversight in Telemedicine
AI chatbots in telemedicine raise healthcare regulatory risks involving medical licensing, FDA oversight, prescribing, patient safety and clinical ...
Read the original at Holland & Knight ↗
- Topics
- HealthcareRegulation & PolicyGovernance & Risk ManagementChatbots & LLMsCopyright & IPAI Safety & Existential Risk
- Mentions
- FDA
- Tracked via
- “AI Risks”